Actively Recruiting
Preimplantation Genetic Testing in Women of Advanced Maternal Age
Led by Genomic Prediction Inc. · Updated on 2025-08-26
240
Participants Needed
1
Research Sites
299 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
CONDITIONS
Official Title
Preimplantation Genetic Testing in Women of Advanced Maternal Age
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged between 35 and 40 years at the start of IVF cycle
- Undergoing IVF with Intracytoplasmic Sperm Injection (ICSI)
- Using ejaculated or testicular sperm
- Using autologous or donor sperm
- Receiving any Controlled Ovarian Hyperstimulation (COH) protocols
You will not qualify if you...
- Diagnosis of anovulatory Polycystic Ovarian Syndrome (PCOS)
- Use of donor oocytes
- Use of a gestational carrier
- History of recurrent pregnancy loss defined as 3 or more consecutive miscarriages
- History of recurrent implantation failure defined as 3 or more failed embryo transfers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IVF Florida Reproductive Associates
Margate, Florida, United States, 33063
Actively Recruiting
Research Team
N
Nathan R Treff, PhD
CONTACT
D
Diego Marin, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here